Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 27:7:1430744.
doi: 10.3389/fdgth.2025.1430744. eCollection 2025.

Clinical performance of Hedia Diabetes Assistant bolus calculator for diabetes management: a real-world retrospective cohort study

Affiliations

Clinical performance of Hedia Diabetes Assistant bolus calculator for diabetes management: a real-world retrospective cohort study

Kenney Fehrenkamp Pedersen et al. Front Digit Health. .

Abstract

Introduction: Individuals living with type 1 diabetes are at risk of long-term complications related to chronic hyperglycemia. Tight glycemic control is recommended but can increase the risk of iatrogenic hypoglycemia. Hedia Diabetes Assistant (HDA) is a bolus calculator that provides users with bolus insulin recommendations based on personalized settings. We aimed to investigate the effects of HDA on a known risk index of hypoglycemia.

Methods: New users from 2019 to 2021 were included if they fulfilled the following criteria: age ≥18 years, ≥5 logs/1st week of use, and ≥1 log for glucose, carbohydrate, and insulin. User data was extracted from the HDA database. The prespecified primary endpoint was change in the Low Blood Glucose Index (LBGI) after 12 weeks of use. Secondary endpoints were changes in the High Blood Glucose Index (HBGI) and eA1c. An exploratory endpoint was to maintain potential improvements in LBGI after 25 weeks. A repeated-measures mixed model with a log-transformation was used.

Results: A total of 1,342 users were included. The mean age was 43.4 years (SD 14.7) with 52.3% being female. After 12 weeks, LBGI significantly improved from 0.73 to 0.61 (17% decrease, P < 0.001) with no significant changes in HBGI, and eA1c. From week 12 to 25, LBGI decreased from 0.61 to 0.55 (10%, P = 0.107).

Conclusions: Users of HDA experienced statistically significant improvement in LBGI after 12 weeks with no changes in HBGI and eA1c, which was successfully maintained after 25 weeks. These results suggest a decreased risk of hypoglycemia when using HDA.

Keywords: bolus calculator; digital technologies; glycemic control; hypoglycemia; type 1 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

KP, GK and AK are employed at Hedia ApS. AØ is a former employee at Hedia ApS. SN is affiliated with Hedia ApS as a biostatistical consultant.

Figures

Figure 1
Figure 1
Flow-chart of user inclusion. eA1c, estimated A1c; HBGI, high blood glucose index; LBGI, low blood glucose index.
Figure 2
Figure 2
Trajectories of LBGI, eA1c, and HBGI from week 0 to week 25. Trajectories of LBGI, eA1c, and HBGI from week 0 to week 25. The figure shows values over time for LBGI (A), HBGI (B), and eA1c (C) Bold week numbers and black points indicate time points of interest, and error bars indicate 95% confidence intervals. The values are geometric means. eA1c, estimated A1c; HBGI, high blood glucose index; LBGI, low blood glucose index.

Similar articles

References

    1. American Diabetes Association Professional Practice Committee. 6. Glycemic goals and hypoglycemia: standards of care in diabetes-2024. Diabetes Care. (2024) 47(Suppl 1):S111–25. 10.2337/dc24-S006 - DOI - PMC - PubMed
    1. den Brok EJ, Svensson CH, Panagiotou M, van Greevenbroek MMJ, Mertens PR, Vazeou A, et al. The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: a systematic review with meta-analysis. Diabetes Obes Metab. (2024) 26(5):1950–61. 10.1111/dom.15521 - DOI - PubMed
    1. Schmidt S, Nørgaard K. Bolus calculators. J Diabetes Sci Technol. (2014) 8(5):1035–41. 10.1177/1932296814532906 - DOI - PMC - PubMed
    1. Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. (2017) 5(5):377–90. 10.1016/S2213-8587(17)30014-1 - DOI - PubMed
    1. Fabris C, Patek SD, Breton MD. Are risk indices derived from CGM interchangeable with SMBG-based indices? J Diabetes Sci Technol. (2015) 10(1):50–9. 10.1177/1932296815599177 - DOI - PMC - PubMed

LinkOut - more resources